Probing the Cytotoxic Signaling Induced by Eupenifeldin in Ovarian Cancer Models

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

Monica A. Haughan; Manead Khin; Zeinab Y. Al Subeh; Yu Gao; Leslie N. Aldrich; Joanna E. Burdette

doi:10.1021/acs.jnatprod.3c00186

Probing the Cytotoxic Signaling Induced by Eupenifeldin in Ovarian Cancer Models

Monica A. Haughan & Joanna E. Burdette et al. · 2023-08-29

High-grade serous ovarian cancer (HGSOC) is the most common and lethal ovarian cancer histotype. Lack of early detection methods, limited therapeutic agents, and low 5-year survival rate reflect the urgent need to develop new therapies. Eupenifeldin, a bistropolone, originally isolated from

NCI NIH HHS

P01 CA125066

NCI NIH HHS

R35 CA209896

NCCIH NIH HHS

T32 AT007533

NCCIH NIH HHS

T32 AT008938

U.S. Department of Health and Human Services

P01 CA125066

U.S. Department of Health and Human Services

R35 CA209896

U.S. Department of Health and Human Services

T32 AT007533

Probing the Cytotoxic Signaling Induced by Eupenifeldin in Ovarian Cancer Models

Links

Journal

Institutions

Authors

Funding